Herbert Lepor

发表

Quantitative evaluation of treatment related changes on multi-parametric MRI after laser interstitial thermal therapy of prostate cancer

Anant Madabhushi, Robert Toth, Satish Viswanath, 2013, Medical Imaging.

Identifying quantitative in vivo multi-parametric MRI features for treatment related changes after laser interstitial thermal therapy of prostate cancer

Anant Madabhushi, Robert Toth, Satish Viswanath, 2014, Neurocomputing.

T1 hyperintensity of bladder urine at prostate MRI: frequency and comparison with urinalysis findings.

James S Babb, Andrew B Rosenkrantz, Herbert Lepor, 2011, Clinical imaging.

Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate.

Run Wang, Herbert Lepor, H. Lepor, 2010, The Journal of urology.

Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.

Ted Lee, Dan Sperling, Herbert Lepor, 2014, Reviews in urology.

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience.

Bob Djavan, Samir S Taneja, Herbert Lepor, 2010, Reviews in urology.

New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.

Mark Emberton, Herbert Lepor, A. Villers, 2017, European urology.

Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate‐specific antigen

Ted Lee, Heather T Gold, Danil V Makarov, 2015, BJU international.

Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

Lori J Sokoll, David H Wilson, Alan W Partin, 2011, Clinical chemistry.

Role of intraoperative biopsies during radical retropubic prostatectomy.

Herbert Lepor, H. Lepor, Ledia Kaci, 2004, Urology.

Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.

C. J. Schettino, Herbert Lepor, S. Taneja, 2004, AJR. American journal of roentgenology.

Clinical evaluation of a novel method for the measurement of prostate‐specific antigen, AccuPSATM, as a predictor of 5‐year biochemical recurrence‐free survival after radical prostatectomy: results of a pilot study

Lori J Sokoll, Alan W Partin, Samir S Taneja, 2012, BJU international.

Quantifying the Smooth Muscle Content of the Prostate Using Double Immunoenzymatic Staining and Color-Assisted Image Analysis

Ellen Shapiro, Herbert Lepor, H. Lepor, 1992 .

Status of radical prostatectomy in 2009: is there medical evidence to justify the robotic approach?

Herbert Lepor, H. Lepor, 2009, Reviews in urology.

The role of gonadotropin-releasing hormone antagonists for the treatment of benign prostatic hyperplasia.

Herbert Lepor, H. Lepor, 2006, Reviews in urology.

Vascular targeted photodynamic therapy for localized prostate cancer.

Herbert Lepor, H. Lepor, 2008, Reviews in urology.

Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations

Herbert Lepor, P. Walsh, H. Lepor, 1983, The Prostate.

Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.

Judith D Goldberg, Herbert Lepor, H. Lepor, 2011, European urology.

Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.

Jurgen J Fütterer, Herbert Lepor, J. Fütterer, 2015, European urology.

Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.

Samir S Taneja, Herbert Lepor, S. Taneja, 2005, The Journal of urology.

Adoption of an integrated radiology reading room within a urologic oncology clinic: initial experience in facilitating clinician consultations.

Michael P Recht, Andrew B Rosenkrantz, Samir S Taneja, 2014, Journal of the American College of Radiology : JACR.

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Andrew B Rosenkrantz, Samir S Taneja, James S Wysock, 2014, The Journal of urology.

Gleason 6 prostate cancer: serious malignancy or toothless lion?

Herbert Lepor, Nicholas M. Donin, H. Lepor, 2014, Oncology.

Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Fang-Ming Deng, Jonathan Melamed, Andrew B Rosenkrantz, 2016, European urology.